Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer.
Zhaoya GaoDandan HuangHui ChenYong YangKe AnChangmin DingZheping YuanZhichao ZhaiPengfei NiuQingkun GaoJinping CaiQingmin ZengYanzhao WangYuming HongWanshui RongWensheng HuangFuming LeiXiaodong WangShiqing ChenXiaochen ZhaoYuezong BaiJin GuPublished in: Journal of translational medicine (2023)
Combining postoperative ctDNA and clinical risk may better predict recurrence than ctDNA alone for developing a personalized postoperative management strategy for CRC.